- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
GYNO-TARDYFERON - - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B03AD03 | B | Folic acid - 0.35mg, Ferrous (sulfate) - 80mg | 1870 | 261032 | GYNO-TARDYFERON | 30 | Tablet, sugar coated, slow release | Oral | Mersaco | Pierre Fabre Medicament Production | France | 682,672 L.L | 23.08 | A1 | Pierre Fabre Pharma AG | Switzerland | 2/5/2024 | 0 |